Inventor · disambiguated record
Gabriela Hernandez-Hoyos
Also filed as: HERNANDEZ-HOYOS GABRIELA
7 granted patents·3 pending applications·15 citations·filing 2017–2025
80Inventor score
Top patents by PatentIndex Score
10 records- 0190US10239949B2Oncofetal antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Granted Mar 26, 2019·6 cites·20 claims
- 0288US11939392B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2021·Granted Mar 26, 2024·1 cites·15 claims
- 0388US10676533B2Methods of treatment of CD123 overexpressing disordersAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Granted Jun 9, 2020·4 cites·9 claims
- 0486US11312786B2Oncofetal antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2019·Granted Apr 26, 2022·2 cites·19 claims
- 0583US11242400B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Granted Feb 8, 2022·2 cites·33 claims
- 0682US12441798B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2024·Granted Oct 14, 2025·0 cites·15 claims
- 0765US11725060B2Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Granted Aug 15, 2023·0 cites·24 claims
- 0857US2024301086A1Tumor-associated antigens and cd3-binding proteins, related compositions, and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2021·Application pending·0 cites
- 0951US2025345431A1Genetically engineered t cells expressing a cd19 chimeric antigen receptor (car) and uses thereof for allogeneic cell therapyJUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1050US2022242962A14-1bb and ox40 binding proteins and related compositions and methods, antibodies against 4-1bb, antibodies against ox40APTEVO RES & DEVELOPMENT LLC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gabriela Hernandez-Hoyos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →